Technical Analysis for MDWD - MediWound Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Historical MDWD trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Reached Oversold | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | -2.70% | |
Down 4 Days in a Row | Weakness | -2.70% | |
Narrow Range Bar | Range Contraction | -4.48% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Up 2% | 1 day ago |
Up 1% | 1 day ago |
Lower Bollinger Band Support | 2 days ago |
Down 2 % | 2 days ago |
Fell Below Previous Day's Low | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2021
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Burns Acute Pain Medical Emergencies Connective Tissue Necrosis Debridement Yavne
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Burns Acute Pain Medical Emergencies Connective Tissue Necrosis Debridement Yavne
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.07 |
52 Week Low | 1.7299 |
Average Volume | 112,297 |
200-Day Moving Average | 4.24 |
50-Day Moving Average | 5.34 |
20-Day Moving Average | 5.11 |
10-Day Moving Average | 5.08 |
Average True Range | 0.31 |
ADX | 14.87 |
+DI | 9.99 |
-DI | 24.74 |
Chandelier Exit (Long, 3 ATRs ) | 4.82 |
Chandelier Exit (Short, 3 ATRs ) | 5.43 |
Upper Bollinger Band | 5.49 |
Lower Bollinger Band | 4.72 |
Percent B (%b) | -0.04 |
BandWidth | 15.19 |
MACD Line | -0.11 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.0518 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.38 | ||||
Resistance 3 (R3) | 5.39 | 5.18 | 5.26 | ||
Resistance 2 (R2) | 5.18 | 5.00 | 5.17 | 5.23 | |
Resistance 1 (R1) | 4.93 | 4.89 | 4.82 | 4.92 | 5.19 |
Pivot Point | 4.72 | 4.72 | 4.66 | 4.71 | 4.72 |
Support 1 (S1) | 4.47 | 4.54 | 4.37 | 4.46 | 4.19 |
Support 2 (S2) | 4.26 | 4.43 | 4.25 | 4.15 | |
Support 3 (S3) | 4.01 | 4.26 | 4.12 | ||
Support 4 (S4) | 4.00 |